Researchers have developed BigRNA, a groundbreaking deep learning model capable of predicting RNA behavior, including tissue-specific expression and splicing, directly from genomic DNA sequences. The model excels in identifying pathogenic variants and could be a game-changer in the development of personalized RNA-based therapies for treating genetic diseases.
J&J, Genmab reveal first-line data for Darzalex Faspro, plus new mantle cell lymphoma results for Imbruvica-Venclexta: #ASH23
The late-breaking abstracts for next month’s American Society of Hematology meeting in San Diego were released Tuesday morning. Here are three notable studies from drugmakers